Viral hepatides: yesterday, today, tomorrow


DOI: https://dx.doi.org/10.18565/epidem.2023.13.2.83-7

Makashova V.V., Nikitina T.S., Ponezheva Zh.B.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
In this year, the Central Research Institute of Epidemiology is 60 years old. The paper presents the scientific activity of the Clinical Department and its divisions from the late 1970s to the present day. The main scientific works conducted under the guidance of scientists, such as Professors A.V. Zmyzgov and A.R. Reizis, are highlighted. At this time, they began to actively studied the cellular and humoral components of immunity, the hemostatis system, the state of the antioxidant system and lipid peroxidation, to test new therapies, such as hyperbaric oxygenation, plasmapheresis, laser therapy, interferons, etc. in patients with viral hepatitis.
Keywords: Clinical Department of Infectious Diseases, Central Research Institute of Epidemiology, viral hepatitis
Read entire article

Literature

1. Blumberg B.S., Alter H.J., Visnich S.A. A new antigen in leukemia sera. JAMA 1965; 191: 541.


2. Dane D.S., Cameron K.H., Brig M. Virus-like particles in the blood serum of patients with Australian antigen-associated hepatitis. Lancet 1970; 1(7649): 695–8. doi:10.1016/s0140-6736(70)90926-8. PMID 4190997


3. Rizzetto M., Canese M.G., Aricò S., Crivelli O., Trepo C., Bonino F. et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18(2): 997–1003. — doi: 10.1136/gut.18.12.997. PMID 75123


4. Press release: The Nobel Prize in Physiology or Medicine 2020. https://www.nobelprize.org/prizes/medicine/2020/press-release/


5. http://86.rospotrebnadzor.ru/news/28-iyulya-vsemirnyj-den-borby-s-gepatitom-28-07-2022


6. http://www.cardio.by/ponimanie-virusnogo-gepatita-kak-globalnoy-problemi-zdravoohraneniya


7. https://www.who.int/ru/campaigns/world-hepatitis-day/2022


8. https://imunofan.ru/intervyu-professora-cznii-epidemiologii-minzdrava-rossii-v-v-lebedeva/


9. Понежева Ж.Б., Макашова В.В., Маннанова И.В. Хронический гепатит С: современные аспекты эпидемиологии, иммунопатогенеза и терапии. /Под ред. В.Г. Акимкина. М.: Медконгресс, 2021. 84 с.


Ponezheva Zh.B., Makashova V.V., Mаnnanova I.V. [Chronic hepatitis C: modern aspects of epidemiology, immunopathogenesis and therapy]. /V.G. Аkimkin, еd. Moscow: Medical Congress, 2021. 84 p.


About the Autors

Professor Vera V. Makashova, MD, Leading Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; veramakashova@yandex.ru; https://orcid.org/0000-0002-0982-35
Tatyana S. Nikitina, Cand. Med. Sci., Academic Secretary, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; nikitina-ts@mail.ru; https://orcid.org/0009-0004-5627-2424
Zhanna B. Ponezheva, MD, Head, Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow Russia; doktorim@mail.ru; https://orcid.org/ 0000-0002-6539-4878


Similar Articles

Back to Content

Бионика Медиа